BirchBioMed Inc. — Regulation A 1-A/A
BirchBioMed Inc. of King City, A6 filed a Regulation A 1-A/A with the SEC on 2024-10-04. Aggregate offering: $10.0M (Tier 2). Industry: Other.
Offering
- Filed: 2024-10-04
- Form: 1-A/A
- Accession: 0001493152-24-039492
- Tier: Tier 2
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 000315324
- Audit status: Audited
- Auditor: Bonadio & Co., LLP
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001670747
- Organized in: A1
- Incorporated: 2015
- Address: 130 Kingscross Drive, King City, A6, L7B 1E6
- Phone: 905-833-3414
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $1.0M
- Cash & equivalents: $877K
- Total liabilities: $2.9M
- Stockholder equity: $-1.9M
- Net income: $-1.3M
People (2)
| Name | Role | Location |
|---|
| Alexander R. Mcclean, Esq. | Signer | King City, A6 |
| Mark S. Miller | Chief Executive Officer | King City, A6 |
Other Reg A filings by this issuer (5)
More